Chunlizhengda Medical Instruments' 2024 Profit Plummets 55%

MT Newswires Live

02/27

Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.

Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.

The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2514808908"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514808908\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514808908?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514808908","market":"us","top_or_hot":-1,"title":"Chunlizhengda Medical Instruments' 2024 Profit Plummets 55%","media":"MT Newswires Live","content":"<html><body><p> Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.</p><p>Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.</p><p>The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chunlizhengda Medical Instruments' 2024 Profit Plummets 55%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChunlizhengda Medical Instruments' 2024 Profit Plummets 55%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-02-27 19:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.</p><p>Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.</p><p>The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0251","symbol_name":"專用設備","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2514808908","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514808908","pubTimestamp":1740656321,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Beijing Chunlizhengda Medical Instruments  recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688236":"春立医疗","BK0251":"专用设备","BK1100":"医疗保健设备","01858":"春立医疗","BK1585":"昨日强势股"},"translate_title":"春立正大医疗器械2024年利润暴跌55%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688236":0.9,"01858":0.9},"content_text":"Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}